These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunologic features of HIV-1-infected women on HAART at delivery. Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI. Cytometry B Clin Cytom; 2008 Jul 15; 74(4):236-43. PubMed ID: 18393385 [Abstract] [Full Text] [Related]
10. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. Martinez V, Diemert MC, Braibant M, Potard V, Charuel JL, Barin F, Costagliola D, Caumes E, Clauvel JP, Autran B, Musset L, ALT ANRS CO15 Study Group. Clin Infect Dis; 2009 Jan 01; 48(1):123-32. PubMed ID: 19035778 [Abstract] [Full Text] [Related]
11. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort. Ratto-Kim S, Garner RP, Kim JH, Jagodzinski LL, Michael NL, Paris R, Redfield RR, Birx DL. J Infect Dis; 2004 Jun 01; 189(11):1988-95. PubMed ID: 15143464 [Abstract] [Full Text] [Related]
12. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M. J Virol; 2007 Sep 01; 81(18):9693-706. PubMed ID: 17609262 [Abstract] [Full Text] [Related]
13. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients]. Zhang HW, Qiu ZF, Li TS. Zhonghua Yi Xue Za Zhi; 2004 Dec 02; 84(23):1973-6. PubMed ID: 15730808 [Abstract] [Full Text] [Related]
16. IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, Kimani J, Embree JE, Plummer FA, Fowke KR. Eur J Immunol; 2006 Feb 02; 36(2):336-44. PubMed ID: 16421946 [Abstract] [Full Text] [Related]
18. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M, Swiss HIV Cohort Study. Clin Infect Dis; 2005 Aug 01; 41(3):361-72. PubMed ID: 16007534 [Abstract] [Full Text] [Related]
19. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V. J Med Virol; 2006 Sep 01; 78(9):1190-7. PubMed ID: 16847959 [Abstract] [Full Text] [Related]
20. Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. Plaeger S, Bermudez S, Mikyas Y, Harawa N, Dickover R, Mark D, Dillon M, Bryson YJ, Boyer PJ, Sinsheimer JS. J Infect Dis; 1999 Jun 01; 179(6):1388-94. PubMed ID: 10228059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]